Eiko Lifesciences Ltd — Board Meeting, 14-05-2025: Board Meeting

Eiko LifeSciences Limited has announced a board meeting approving the audited standalone and consolidated financial results for the quarter and year ended March 31, 2025, with an unmodified audit opinion. Consolidated revenue stood at INR 37.66 Cr, yielding a profit before tax of INR 3.06 Cr and net profit of INR 2.32 Cr. The standalone business reported revenue of INR 32.49 Cr and PAT of INR 1.74 Cr. An exceptional item of INR 0.34 Cr relates to interest income from delayed payments of rights shares calls. The company appointed M/s Shravan Gupta & Associates as Secretarial Auditor for five years and M/s NP Rajput & Co. as Internal Auditor for FY 2025-26.